IQVIA (NYSE:IQV – Get Free Report) had its price target lifted by Morgan Stanley from $245.00 to $250.00 in a report released on Tuesday,Benzinga reports. The brokerage presently has an “overweight” ...

Heads of CeraVe In true CeraVe medutainment style, this integrated and immersive campaign was meticulously designed to encourage aud ...

IQVIA to create northern 'Prime Site' for R ... “I want the UK to have the most advanced health and care system on the planet. Technology and artificial intelligence have the potential to ...

Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch1 of Clindamycin Phosphate Foam, 1%. Glenmark's Clindamycin Phosphate Foam, 1% is bioequivalent and therapeutically equivalent to the ...

This was the stock's fourth consecutive day of losses.

Request To Download Free Sample of This Strategic Report @ Highlighted with 99 tables and 79 figures, this 186-page report ?Asia Pacific Clinical Trials Market 2022-2031 by Product Category (Drugs, ...

Request To Download Free Sample of This Strategic Report @ Highlighted with 89 tables and 75 figures, this 178-page report ?North America Clinical Trials Market 2022-2031 by Product Category (Drugs, ...

Emily Fontaine, Global Head of Venture Capital, IBM; Jay Love, US Chief Investment Strategist, Mercer; and Alan McKnight, Chief Investment Officer, Regions Bank join Bloomberg Intelligence's ...